EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.3.1.255 | Heart Defects, Congenital |
33557580 |
Mechanisms of Congenital Heart Disease Caused by NAA15 Haploinsufficiency. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 2.3.1.255 | Infertility |
32461302 |
NAA50 Is an Enzymatically Active N?-Acetyltransferase That Is Crucial for Development and Regulation of Stress Responses. |
unassigned |
0 |
| 2.3.1.255 | Insulin Resistance |
33296651 |
Reduction of mNAT1/hNAT2 Contributes to Cerebral Endothelial Necroptosis and A? Accumulation in Alzheimer's Disease. |
causal interaction
ongoing research
unassigned |
1
2
0 |
| 2.3.1.255 | Intellectual Disability |
28990276 |
Exome sequencing reveals NAA15 and PUF60 as candidate genes associated with intellectual disability. |
causal interaction
unassigned |
2
0 |
| 2.3.1.255 | Intellectual Disability |
29656860 |
Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies. |
causal interaction
unassigned |
3
0 |
| 2.3.1.255 | Intellectual Disability |
33103328 |
Variants in NAA15 cause pediatric hypertrophic cardiomyopathy. |
causal interaction
diagnostic usage
unassigned |
3
1
0 |
| 2.3.1.255 | Neoplasms |
19716809 |
Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradation. |
ongoing research
unassigned |
4
0 |
| 2.3.1.255 | Neoplasms |
23557624 |
Design, Synthesis, and Kinetic Characterization of Protein N-Terminal Acetyltransferase Inhibitors. |
causal interaction
diagnostic usage
unassigned |
4
1
0 |
| 2.3.1.255 | Prostatic Neoplasms |
27659526 |
Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis. |
causal interaction
ongoing research
unassigned |
3
2
0 |
| 2.3.1.255 | Starvation |
25330189 |
daf-31 encodes the catalytic subunit of N alpha-acetyltransferase that regulates Caenorhabditis elegans development, metabolism and adult lifespan. |
therapeutic application
unassigned |
4
0 |
